The influence of modified molecular (D/L-serine) chirality on the theragnostic of PAMAM-based nanomedicine for acute kidney injury

2021 ◽  
Author(s):  
Lulu Kong ◽  
Di Fan ◽  
Lin Zhou ◽  
Shaohua Wei
Keyword(s):  
Acute Kidney Injury ◽  
Early Detection ◽  
Kidney Injury ◽  
Clinical Disease ◽  
Morbidity And Mortality ◽  
High Morbidity ◽  
Simple Method

Acute kidney injury (AKI) is a severe clinical disease with extremely high morbidity and mortality. It is challenging to find a simple method for early detection of AKI and monitoring...

MO370PREGNANCY-RELATED ACUTE KIDNEY INJURY IN TUNISIA: A CLINICAL CHALLENGE

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Menel Msehli ◽  
Hela Jbali ◽  
Mami Ikram ◽  
Badreddine Ben kaab ◽  
Fethi Ben hamida ◽  
...  
Keyword(s):  
Risk Factors ◽  
Acute Kidney Injury ◽  
Renal Failure ◽  
Prenatal Care ◽  
Clinical Manifestations ◽  
Kidney Injury ◽  
Morbidity And Mortality ◽  
Renal Outcome ◽  
Clinical Feature ◽  
High Morbidity

Abstract Background and Aims Acute kidney injury (AKI) is a complex disorder that occurs in several clinical settings. During pregnancy, there are additional unique conditions that contribute to AKI. The clinical manifestations of Pregnancy related acute kidney injury(PRAKI) range from a minimal elevation in serum creatinine to severe renal failure requiring renal replacement therapy and may be associated with significant morbidity and mortality in young healthy women. This study aims to describe epidemiologic features, study clinical profile and outcomes of women with PRAKI and identify risk factors related to requiring hemodialysis among patients. Method We performed a retrospective study over a 5-year period (2015–2019) in a Tunisian intensive care unit. All patients presenting PRAKI were included. Results Ninety-six cases of PRAKI were listed. The rate of AKI during pregnancy-related hospitalizations was 16% .the average age was 31 ± 5 years. Most women were from urban areas (62%) but with insufficient prenatal care (57%).Seventy-eight percent underwent cesarean section delivery. PRAKI occurred in the postpartum in 79%of the cases. Oligo-anuria was the most common clinical feature of PRAKI, noted in 82% of our patients. The leading etiological causes were pre eclampsia, eclampsia, postpartum haemorrhage and sepsis respectively, in 49%, 38%, and 24% of the cases. Hemodialysis was required in 23% of cases. In the adjusted regression analysis, factors associated with dialysis were insufficient prenatal care (p=0,010 ; O Ra=24,113), HELLP syndrome (p=0,003 ; ORa=35,129), disseminated intravascular coagulation (p=0,007 ; OR=11,854), average duration of oliguria (p=0,001; ORa=3,025) , Failure stage of RIFLE criteria while admitted (p=0,009; ORa=2,09) and length of ICU stay (p=0,042 ; ORa=1,118). Renal outcome was favorable, with a complete renal function recovery for 72 patients (75%). Only four patients (4%) developed chronic renal failure. Mortality rate was 13%. Conclusion PRAKI is a dreaded complication of pregnancy with high morbidity and mortality. Prevention of PRAKI requires an improvement of the sanitary infrastructures with the implementation of an obligatory prenatal consultation in order to prompt management of the underlying risk factors

scholarly journals Predictive Ability of Procalcitonin for Acute Kidney Injury: A Narrative Review Focusing on the Interference of Infection

2021 ◽  
Vol 22 (13) ◽  
pp. 6903
Author(s):  
Wei-Chih Kan ◽  
Ya-Ting Huang ◽  
Vin-Cent Wu ◽  
Chih-Chung Shiao
Keyword(s):  
Acute Kidney Injury ◽  
Kidney Injury ◽  
Predictive Ability ◽  
Morbidity And Mortality ◽  
Clinical Settings ◽  
High Morbidity ◽  
Timely Manner ◽  
Current Review ◽  
Potential Biomarker ◽  
Infection And Inflammation

Acute kidney injury (AKI) is a common yet complicated clinical entity with high morbidity and mortality. An essential strategy to improve AKI patients’ prognoses is finding optimal biomarkers to identify AKI in a timely manner. Procalcitonin (PCT), a well-recognized biomarker for diagnosing infection and guiding antibiotics therapy, has been proposed to predict AKI development and recovery in many clinical settings. The current review provides comprehensive and updated information from relevant studies to evaluate PCT’s AKI-predictive ability and the influence of infection on this predictive ability. PCT has demonstrated optimal predictive ability for AKI in various populations irrespective of infection. However, the predictive ability seems to be blunted by infection since infection and inflammation have a more potent influence than AKI on PCT elevation. We furthermore explain the complicated association between elevated PCT levels and AKI in infection and inflammation situations and recommend directions for further investigations to clarify the essential issue. In conclusion, although conflicting data exist, serum PCT level is a potential biomarker for predicting AKI in many clinical settings regardless of infection. Nevertheless, further studies are warranted to clarify the association between PCT, infection, and AKI and to confirm the utilization of PCT for AKI prediction.

scholarly journals Etiology & Outcome of Acute kidney Injury in Intensive Care Unit Settings of a Tertiary Care Hospital

2020 ◽  
Vol 4 (2) ◽  
pp. 01-05
Author(s):  
Hassan Mumtaz
Keyword(s):  
Intensive Care Unit ◽  
Acute Kidney Injury ◽  
Risk Factor ◽  
Intensive Care ◽  
Tertiary Care ◽  
Hospital Setting ◽  
Kidney Injury ◽  
Morbidity And Mortality ◽  
High Morbidity ◽  
Care Hospital

Introduction: Acute kidney injury (AKI) is defined as a rapid loss of kidney function occurring over few hours or days. In intensive care unit settings, acute kidney injury (AKI) is a very prevalent condition as most of the patients who are admitted in intensive care units are critically ill. The incidence of acute kidney injury is increasing throughout the world mainly because of aging population and co morbidities which are associated with aging. In intensive care unit settings, the incidence of AKI may reach up to 67%. Though AKI effects depend on clinical situation yet associated with high morbidity and mortality. The rationale of this study is that, as acute kidney is one of major factors contributing in mortality and morbidity of ICU patients, this study will be helpful in identifying important risk factor for development of acute kidney injury in ICU settings, leading to its early detection and thus decreasing associated morbidity and mortality. Objective: To determine the frequency of etiology and outcome of acute kidney injury in medical intensive care unit of KRL Hospital. Setting: Medical ICU, KRL Hospital, Islamabad. Duration: six months from 17th May 2017 to 17th November 2017. Study design: Descriptive case series. Material and method: In this study 118 patients were observed. After screening and application of exclusion criteria, a total of 118 patients who were fulfilling the inclusion criteria were selected as the study sample and were included in the final analysis regarding prevalence of risk factors associated with AKI and the outcome associated with AKI. AKI was further classified using acute kidney injury network (AKIN) classification system. Patient age, gender, serum creatinine, etiology and outcome in form of recovery or mortality was recorded. Results: Overall incidence of AKI in ICU settings in this study was 37.8% (n=118). Out of 118 patients who had AKI, 59.3% (n=70) were male, whereas 40.7% (n=48) were females. Most common risk factor associated with development of AKI was sepsis secondary to infectious illnesses and 39% (n=46) of the patients who developed AKI were suffering from infectious illnesses. Gastrointestinal, drugs and cardiac causes constitutes the 32.2 % (n=38), 18.6% (n=22) and 10.2% (n=12) respectively of the AKI in ICU settings. In terms of outcome, mortality rate in patients with AKI was significantly higher as compared to patients without AKI(P =<0.001) and 56.8%(n=67) of the patients who had AKI died during their ICU stay as compared to 30.4%(n=59) in patients without AKI. Conclusion: Our study concludes that the frequency of etiology including infectious causes was 39%, cardiac pathology 10%, GI causes 32%, drugs was 19% and mortality was 56.8% in patients with acute kidney injury.

scholarly journals Biomarkers of acute kidney injury in a mixed ICU population. a narrative review

2019 ◽  
Vol 5 (4) ◽  
pp. 150
Author(s):  
Dimitrios Panagidis ◽  
Serafim Nanas ◽  
Stelios Kokkoris
Keyword(s):  
Acute Kidney Injury ◽  
Renal Failure ◽  
Intensive Care ◽  
Early Detection ◽  
Predictive Accuracy ◽  
Kidney Injury ◽  
Predictive Ability ◽  
Risk Groups ◽  
Morbidity And Mortality ◽  
Adult Intensive Care Unit

Introduction: Acute kidney injury is a severe complication occurring in critically ill patients treated in the intensive care units, which has a significant impact on morbidity and mortality in these patients. Moreover, despite technological and pharmaceutical advances during the last decades, acute kidney injury is still associated with markedly increased morbidity and mortality. Creatinine, the most common renal dysfunction biomarker in use, has poor predictive accuracy for renal injury due to time delay in its increase and the influence by other factors on its serum concentration such as age, gender, muscle mass etc. Therefore, the need for better renal biomarkers in order to early detect and intervene for acute kidney injury prevention is imperative. During the last years several new acute kidney injury biomarkers have been discovered and validated to improve early detection of patients in risk groups for progressive renal failure, need for renal replacement therapy or death. Aim: The purpose of the present article is to review the studies that have tested the predictive ability of those biomarkers (in urine and/or plasma) for early detection of acute kidney injury in the mixed adult intensive care unit population. Material and Method: We searched Medline (PubMed) using the keywords: acute kidney injury, biomarkers, renal failure, ICU.Results: The most relevant articles were included in this review.Conclusions: During the past decade, multiple AKI biomarkers have been studied and viewed as promising. Further studies are needed to determine their clinical utility.

scholarly journals Daily Urinary Sodium Excretion Monitoring in Critical Care Setting: A Simple Method for an Early Detection of Acute Kidney Injury

2021 ◽  
Vol 0 (0) ◽  
pp. 0
Author(s):  
CarlosG Musso ◽  
Diana Silva ◽  
Fernanda Propato ◽  
Yeny Molina ◽  
María de losÁngeles Velez-Verbel ◽  
...  
Keyword(s):  
Acute Kidney Injury ◽  
Critical Care ◽  
Early Detection ◽  
Sodium Excretion ◽  
Care Setting ◽  
Kidney Injury ◽  
Urinary Sodium Excretion ◽  
Urinary Sodium ◽  
Critical Care Setting ◽  
Simple Method

Long non-coding RNA SNHG14 aggravates LPS-induced acute kidney injury through regulating miR-495-3p/HIPK1

2021 ◽  
Author(s):  
Ni Yang ◽  
Hai Wang ◽  
Li Zhang ◽  
Junhua Lv ◽  
Zequn Niu ◽  
...  
Keyword(s):  
Cell Proliferation ◽  
Acute Kidney Injury ◽  
Inflammatory Cytokine ◽  
Cytokine Production ◽  
Kidney Injury ◽  
Interaction Network ◽  
High Morbidity ◽  
Abrupt Decrease ◽  
Inflammatory Cytokine Production ◽  
Non Coding Rna

Abstract Acute kidney injury (AKI) is a complex syndrome with an abrupt decrease of kidney function, which is associated with high morbidity and mortality. Sepsis is the common cause of AKI. Mounting evidence has demonstrated that long non-coding RNAs (lncRNAs) play critical roles in the development and progression of sepsis-induced AKI. In this study, we aimed to illustrate the function and mechanism of lncRNA SNHG14 in lipopolysaccharide (LPS)-induced AKI. We found that SNHG14 was highly expressed in the plasma of sepsis patients with AKI. SNHG14 inhibited cell proliferation and autophagy and promoted cell apoptosis and inflammatory cytokine production in LPS-stimulated HK-2 cells. Functionally, SNHG14 acted as a competing endogenous RNA (ceRNA) to negatively regulate miR-495-3p expression in HK-2 cells. Furthermore, we identified that HIPK1 is a direct target of miR-495-3p in HK-2 cells. We also revealed that the SNHG14/miR-495-3p/HIPK1 interaction network regulated HK-2 cell proliferation, apoptosis, autophagy, and inflammatory cytokine production upon LPS stimulation. In addition, we demonstrated that the SNHG14/miR-495-3p/HIPK1 interaction network regulated the production of inflammatory cytokines (TNF-α, IL-6, and IL-1β) via modulating NF-κB/p65 signaling in LPS-challenged HK-2 cells. In conclusion, our findings suggested a novel therapeutic axis of SNHG14/miR-495-3p/HIPK1 to treat sepsis-induced AKI.

Sign in / Sign up

Export Citation Format

Share Document